Form 4: Blue Bird CFO Sells 10,000 Shares Under Pre-Arranged Trading Plan

Blue Bird Corporation's Chief Financial Officer, Razvan Radulescu, sold 10,000 shares of common stock for a weighted average price of $45.19 per share on July 8, 2025, as part of a pre-existing Rule 10b5-1 trading plan.

Summary

• Razvan Radulescu, Chief Financial Officer of Blue Bird Corp (BLBD), sold 10,000 shares of the company's common stock.
• The transaction occurred on July 8, 2025.
• The shares were sold at a weighted average price of $45.19, with individual sales ranging from $44.86 to $45.29 per share.
• Following this transaction, Razvan Radulescu beneficially owns 58,203 shares of Blue Bird Corp common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on August 12, 2024.

Sentiment

Score: 5

Explanation: A neutral score. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-planned 10b5-1 trading plan mitigates concerns that it's based on new, negative information. It's a routine transaction for personal financial planning.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on new, non-public information.

Negatives

• An insider sale, even if pre-planned, reduces the direct equity stake of a key executive in the company.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it primarily reports a past transaction.

Industry Context

This Form 4 filing reports a routine insider transaction under a pre-arranged trading plan and does not provide information relevant to broader industry trends or competitor analysis.

Stakeholder Impact

• Shareholders: The sale by a key executive, even if pre-planned, slightly reduces management's direct equity alignment with shareholders, though the CFO still retains a significant holding.

Key Dates

Recommendation

Keywords

Blue Bird Corp, BLBD, Form 4, Insider Trading, Stock Sale, CFO, Razvan Radulescu, Rule 10b5-1, Equity Transaction, Corporate Officer